Omeprazole
From £12.99
Understanding PPI Dosage Strengths for Acid Reflux
Standard PPI Dosages for Acid Reflux Treatment
Proton pump inhibitors represent the most effective class of medications for acid reflux management. Omeprazole 20mg capsules serve as the gold standard treatment, typically taken once daily before breakfast for optimal acid suppression. This dosage effectively manages symptoms in approximately 80% of patients with gastro-oesophageal reflux disease (GORD).
Alternative PPI Options and Strengths
Lansoprazole 15mg capsules offer an alternative approach, particularly suitable for patients requiring lower-dose maintenance therapy. The 15mg strength provides effective acid suppression whilst minimising potential side effects associated with higher doses. Pantoprazole 20mg tablets represent another reliable option, especially favoured for long-term treatment due to their favourable interaction profile with other medications.
Branded vs Generic PPI Formulations
EverydayMeds stocks both generic omeprazole 20mg capsules and branded Losec MUPS 20mg tablets. Losec MUPS utilises multiple unit pellet system technology, allowing for consistent drug release and potentially improved patient tolerance. Both formulations contain identical active ingredients and demonstrate equivalent therapeutic efficacy for acid reflux management.
H2 Receptor Antagonist Alternative
Famotidine tablets provide an effective alternative for patients who cannot tolerate PPIs or require additional acid suppression. H2 blockers work through a different mechanism, blocking histamine receptors in the stomach lining. This option proves particularly valuable for breakthrough symptoms or combination therapy approaches.
Treatment Duration and Dosage Adjustment
Initial treatment typically involves 4-8 weeks of standard-dose PPI therapy. Patients experiencing incomplete symptom resolution may require dose optimisation or alternative PPI selection. Maintenance therapy often utilises lower doses, with lansoprazole 15mg proving particularly effective for preventing symptom recurrence whilst minimising long-term medication exposure.
